MedPath

Sleep, Lifestyle, Energy, Eating, Exercise Program for the management of sleep apnea patients indicated for weight loss treatment: A randomised, controlled pilot study.

Not Applicable
Completed
Conditions
Obstructive Sleep Apnoea
Obesity
Respiratory - Sleep apnoea
Diet and Nutrition - Obesity
Registration Number
ACTRN12613000191796
Lead Sponsor
The Woolcock Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
42
Inclusion Criteria

The following inclusion criteria enable the volunteer to participate in the SLEEEP Study:
Males & Females aged 18-65 years.

General or central obesity: BMI: greater than or equal to 30kg/m2 (greater than or equal to 26kg/m2 amongst non-Europeans) or waist circumference greater than or equal to 88cm for women and greater than or equal to 102cm for men (greater than or equal to 90cm in men and greater than or equal to 80cm in women who are non-European).

Willing and medically able to participate in a supervised very low energy diet (Optifast) and the dietary and lifestyle modification groups for a 12 month period.

Mild-severe, symptomatic OSA (degree of symptoms at the treating physician’s discretion based on overnight sleep study report)

No history of or current presence of eating disorders , significant/extensive food allergies or significant food intolerances (e.g. coeliac disease)

Willing and able to complete all assessments outlined in participant information sheet

Hold a current driver’s license or have access to transport.

Exclusion Criteria

Unstable aortic aneurysm
Rapidly progressive or terminal illness
Severe left ventricular dysfunction/end stage congestive heart failure
Severe aortic stenosis
Severe psychosis or behavioural disturbance or cognitive impairment
Patients known to be involved in illegal activity

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in waist circumference (measured in cm)<br>This outcome was ethically approved on 1/3/16.[Change between 2 and 12 months]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath